ANIVANCE AI Trademark
Trademark Overview
On Monday, June 9, 2025, a trademark application was filed for ANIVANCE AI with the United States Patent and Trademark Office. The USPTO has given the ANIVANCE AI trademark a serial number of 99224937. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 6, 2026. This trademark is owned by Anivance AI Corporation. The ANIVANCE AI trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Organ-on-a-chip for laboratory and research purposes; Biotechnology instruments in the nature of microscopes; Microfluidic systems comprised of electric microfluidic sensors and microfluidic chips; Cell culture devices for laboratory use, namely, cell culture dishes, and tissue culture flasks; Scientific laboratory research instruments for DNA analysis; Biological simulation devices in the nature of medical training simulators; Diagnostic microfluidic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, DNA analysis, and thermal imaging; In vitro diagnostic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, and DNA analysis
Research and development services in the field of biotechnology; Organ-on-a-chip development and design; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals; Technical consultation and support services in the field of biosequestration of carbon dioxide; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals in the field of cellular biology; Laboratory services for the production of pharmaceuticals in the nature of providing simulations of cells in the field of cellular biology; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of human tissue for cellular biology purposes; Research and development in the field of cellular biology; Development of biological simulation systems; Development of microfluidic technology; Diagnostic services for organ-on-a-chip systems; Medical research services in the field...
Medical diagnostic services; Personalized medical services in the nature of emergency medical services; Health assessment services and managed health care services; Medical evaluation of cell therapy
Artificial organ-on-a-chip for medical use; Diagnostic microfluidic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; In vitro diagnostic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Cell therapy devices in the nature of medical devices being tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical testing chips being lab-on-a-chip in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Medical biological simulation devices in the nature of medical diagnostic apparatus for detecting disease progression and also incorporating recorded software for simulating organ functions and drug interactions; Medical instruments, namely...
General Information
| Serial Number | 99224937 |
| Word Mark | ANIVANCE AI |
| Filing Date | Monday, June 9, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, January 6, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, January 6, 2026 |
Trademark Statements
| NOT AVAILABLE | "AI" |
| Goods and Services | Organ-on-a-chip for laboratory and research purposes; Biotechnology instruments in the nature of microscopes; Microfluidic systems comprised of electric microfluidic sensors and microfluidic chips; Cell culture devices for laboratory use, namely, cell culture dishes, and tissue culture flasks; Scientific laboratory research instruments for DNA analysis; Biological simulation devices in the nature of medical training simulators; Diagnostic microfluidic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, DNA analysis, and thermal imaging; In vitro diagnostic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, and DNA analysis |
| Description of Mark | The mark consists of the words "ANIVANCE AI" in stylized letters. |
| Goods and Services | Research and development services in the field of biotechnology; Organ-on-a-chip development and design; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals; Technical consultation and support services in the field of biosequestration of carbon dioxide; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals in the field of cellular biology; Laboratory services for the production of pharmaceuticals in the nature of providing simulations of cells in the field of cellular biology; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of human tissue for cellular biology purposes; Research and development in the field of cellular biology; Development of biological simulation systems; Development of microfluidic technology; Diagnostic services for organ-on-a-chip systems; Medical research services in the field of regenerative medicine |
| Pseudo Mark | ANIVANCE ARTIFICIAL INTELLIGENCE |
| Goods and Services | Medical diagnostic services; Personalized medical services in the nature of emergency medical services; Health assessment services and managed health care services; Medical evaluation of cell therapy |
| Goods and Services | Artificial organ-on-a-chip for medical use; Diagnostic microfluidic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; In vitro diagnostic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Cell therapy devices in the nature of medical devices being tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical testing chips being lab-on-a-chip in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Medical biological simulation devices in the nature of medical diagnostic apparatus for detecting disease progression and also incorporating recorded software for simulating organ functions and drug interactions; Medical instruments, namely, biosensors for detecting infectious diseases; Cell culture devices in the nature of cell culture apparatus for medical use, namely, cell culture chambers |
Classification Information
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 9, 2025 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 9, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 9, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 9, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Anivance AI Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Zhubei City, Hsinchu County R.O.C.
TW |
| Party Name | Anivance AI Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Zhubei City, Hsinchu County R.O.C.
TW |
Trademark Events
| Event Date | Event Description |
| Monday, June 9, 2025 | NEW APPLICATION ENTERED |
| Monday, June 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 15, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 29, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, October 29, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 29, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 29, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 5, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 5, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 5, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 8, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 31, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 6, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 6, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
